Resources Management Corp Rallybio Corp Transaction History

Resources Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.91 - $4.39 $473 - $1,088	248 Added 12400.0%	250 $1,000
Q4 2023 Feb 14, 2024	SELL	$1.91 - $4.39 $473 - $1,088	-248 Reduced 99.2%	2 $1,000
Q2 2023 Aug 16, 2023	SELL	$4.31 - $8.89 $861 - $1,778	-200 Reduced 44.44%	250 $1,000
Q1 2023 May 11, 2023	BUY	$4.37 - $8.75 $874 - $1,750	200 Added 80.0%	450 $44,000
Q3 2021 Nov 12, 2021	BUY	$10.83 - $23.4 $2,707 - $5,850	250 New	250 $4,000

31.9M

Ticker RLYB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,132,000
Market Cap $31.8M
Description
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

Stay updated on Resources Management Corp with notifications on news.